KRAS-Mutant NSCLC | OncLive
KRAS-Mutant NSCLC | OncLive
Sep 1, 2020
onclive.com
Dr. Skoulidis on the Results of Subgroup Analyses of the CodeBreaK 100 Trial in KRAS G12C-Mutant NSCLC | OncLive
Dr. Skoulidis on the Results of Subgroup Analyses of the CodeBr…
Jun 4, 2021
onclive.com
Dr Herzberg on Future Research Directions in KRAS-Mutant NSCLC
Dr Herzberg on Future Research Directions in KRAS-Mutant NSCLC
10 months ago
onclive.com
Treatment Strategies for Metastatic KRAS-Mutant NSCLC
Treatment Strategies for Metastatic KRAS-Mutant NSCLC
105 viewsDec 3, 2024
vumedi.com
Targeted Therapy for KRAS-Mutant NSCLC | OncLive
Targeted Therapy for KRAS-Mutant NSCLC | OncLive
Oct 18, 2019
onclive.com
What is KRAS Cancer Mutation
What is KRAS Cancer Mutation
Mar 25, 2021
kraskickers.org
Treating ALK-Mutant and KRAS G12C–Mutant NSCLC | OncLive
Treating ALK-Mutant and KRAS G12C–Mutant NSCLC | OncLive
2K viewsNov 19, 2021
onclive.com
Treatment of KRAS G12C Mutant NSCLC
May 11, 2022
onclive.com
What is the <em>KRAS</em>-Variant
Feb 19, 2014
mirakind.org
Oncolytics Biotech receives FDA fast track designation for pelareor…
1 month ago
marketscreener.com
Dr Garrido-Laguna on the Mechanism of Action of RMC-623…
Oct 27, 2023
onclive.com
Adagrasib for Patients with KRAS G12C–Mutant NSCLC | OncLive
Sep 12, 2023
onclive.com
Targeting KRAS in Pancreatic Cancer: A Long But Successful Cl…
10 months ago
vumedi.com
1:49
Dr Johnson on the Efficacy of RMC-6236 in KRAS-Mutant NSCLC | On…
1 week ago
onclive.com
Adagrasib Yields Durable Benefit for Patients With KRAS G12C–Mutant …
Sep 10, 2023
onclive.com
I/O Therapy in KRAS-Mutant NSCLC With Concomitant STK11 or KEAP…
Jun 27, 2022
onclive.com
13:20
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tu…
1 week ago
onclive.com
Dr Arbour on the Safety and Efficacy of RMC-6236 in KRAS-Mutant NSC…
Oct 26, 2023
onclive.com
Dr. Iams on the Evaluation of Sotorasib in KRAS G12C–Mutant …
Aug 7, 2022
onclive.com
1:30
Dr Arbour on the Role of Zoldonrasib in KRAS G12D–Mutan…
1 week ago
onclive.com
Dr. Spira on the FDA Approval of Adagrasib in KRAS G12C–mutant …
1 month ago
onclive.com
Dr Hong on Preliminary Activity With RMC-6291 in Advanced KRA…
Oct 18, 2023
onclive.com
Dr Desai on the Efficacy of Divarasib Plus Cetuximab in KRAS G12C–M…
1 week ago
onclive.com
7:16
Patient Advocate and Caregiver Shares Advocacy Journey in KRA…
5 months ago
curetoday.com
Dr Kopetz on the Future Utility of Adagrasib/Cetuximab in KRAS G1…
Apr 30, 2024
onclive.com
KRAS Mutations in Solid Tumors | OncLive
Aug 3, 2020
onclive.com
Dr. Klempner on the Significance of KRYSTAL-1 Data in KRAS G12C–…
Nov 9, 2022
onclive.com
Dr Goldberg on the Investigation of VIC-1911 With/Without Sotorasib i…
1 week ago
onclive.com
Testing for KRAS Mutations in NSCLC | OncLive
Aug 3, 2020
onclive.com
WCLC 2025 Summary: Oncogene-Addicted NSCLC - Taletrectinib (R…
4 months ago
vumedi.com
See more videos
Static thumbnail place holder